DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
J Exp Clin Cancer Res. 2019 Nov 26;38(1):474. doi: 10.1186/s13046-019-1442-2.
J Exp Clin Cancer Res. 2019.
PMID: 31771617
Free PMC article.